Work

Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia

Year: 2019

Type: article

Source: Haematologica

DOI: 10.3324/haematol.2019.236810

Authors: Ramzi Abboud, Ezhilarasi Chendamarai, Michael P. Rettig, Kathryn M. Trinkaus, Peter A. Riedell, Camille N. Abboud, Armin Ghobadi, Iskra Pusic, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy

Institution: Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: American Society of Hematology, Alvin J. Siteman Cancer Center, National Institutes of Health, National Cancer Institute

Awards: G1114310655, G299873027, Washington University Cancer Genomics and Outcomes Research STRENGTH Program, G8242737674, G9000319192, BM NICHE DISRUPTION AND IMMUNOTHERAPY IN HEMATOLOGICAL MALIGNANCIES, Cancer Center Support Grant

OpenAlex ID: W2991237757

FWCI: 1.766

Cites: 13

Cited by: 24

Related to: 10